Free Trial
→ Trump goes 'all-in' on Grand Canyon energy breakthrough (From Behind the Markets) (Ad)tc pixel
NASDAQ:AEMD

Aethlon Medical Q2 2027 Earnings Date & Estimates

Aethlon Medical logo
$5.15 -0.12 (-2.28%)
Closing price 10/16/2026 04:00 PM Eastern
Extended Trading
$5.16 +0.00 (+0.10%)
As of 10/16/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Aethlon Medical is estimated to report Q2 2027 earnings on Wednesday, November 11, 2026. The conference call is scheduled for 4:30 PM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q2 2027
Announcement Date
Conference Call
4:30 PM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Aethlon Medical in Q2 2027

Aethlon Medical is expected to post earnings of -$2.91 per share. In the same quarter a year earlier Aethlon Medical reported -$18.70 per share. Aethlon Medical last reported on August 13, 2026, posting -$4.02 per share and missing the -$3.92 consensus estimate. Aethlon Medical has beaten the consensus EPS estimate in 1 of its last 5 quarters.

Consensus Estimates

Consensus EPS
-$2.91
Prior-Year EPS
-$18.70

Recent Track Record

Last Reported
Q1 2027
Last Quarter EPS
-$4.02 (Missed by -$0.10)
EPS Beat Rate
1 of last 5 quarters

Prepare for the Q2 2027 Call

Aethlon Medical Q2 2027 Earnings FAQ

Aethlon Medical (NASDAQ:AEMD) is estimated to report Q2 2027 earnings on Wednesday, November 11, 2026. This date is estimated from past reporting schedules and may change once the company confirms it.

Aethlon Medical's Q2 2027 earnings conference call is scheduled for Wednesday, November 11, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Aethlon Medical to post earnings of -$2.91 per share for Q2 2027.

Aethlon Medical Earnings Headlines

Aethlon Medical (NASDAQ:AEMD) Stock Rating Raised to "Sell" at Wall Street Zen
October 17 at 1:07 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31126937
Aethlon Medical (NASDAQ:AEMD) Shares Break Below 200 Day Moving Average - Here's Why
October 13, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31113544
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years. While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million. One company controls the entire supply chain behind this discovery.tc pixel
 |  Behind the Markets (Ad)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Aethlon Medical (AEMD), Xenon (XENE) and Oculis Holding (OCS)
September 19, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/XENE-Q/pressreleases/4693092/analysts-have-conflicting-sentiments-on-these-healthcare-companies-aethlon-medical-aemd-xenon-xene-and-oculis-holding-ocs/
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Aethlon Medical, Inc. (NASDAQ: AEMD)
September 18, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/shareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-aethlon-medical-inc-nasdaq-aemd-302883442.html
Aethlon stock pulls back: What's going on?
September 18, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/aethlon-stock-pulls-back-whats-going-on/ar-AA2cwgm8
See More Aethlon Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Aethlon Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aethlon Medical and other key companies, straight to your email.

About Aethlon Medical

Aethlon Medical (NASDAQ:AEMD) is a medical technology company focused on developing extracorporeal filtration systems designed to remove harmful biological materials from the blood. The company’s primary technology is the Hemopurifier, an investigational device intended to capture disease-related particles, including exosomes and certain viruses, during blood filtration.

The Hemopurifier is being studied for potential applications in oncology and infectious disease. In cancer research, the device is designed to remove tumor-derived exosomes, which may contribute to immune suppression and disease progression. In infectious disease applications, it is intended to capture circulating viruses and other pathogens from the bloodstream.

Founded in 2001 and headquartered in San Diego, California, Aethlon Medical’s products remain in the clinical-development and investigational stages. The company has pursued regulatory and clinical activities in the United States and has evaluated its technology through collaborations and studies involving cancer and viral infections.

View Aethlon Medical Profile
Earnings Tools